TransMedics Group, Inc. (TMDX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for TransMedics Group, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 21.73x | 58.42x | -102.55x | -50.35x | -11.97x | -17.10x |
| P/B Ratio | 8.74x | 9.06x | 18.71x | 9.74x | 7.80x | 4.73x |
| P/S Ratio | 6.83x | 4.69x | 10.62x | 19.52x | 17.49x | 19.17x |
| Profitability | ||||||
| Gross Margin | 59.9% | 59.4% | 63.8% | 69.8% | 69.9% | 64.9% |
| Operating Margin | 17.9% | 8.5% | -11.9% | -33.6% | -130.3% | -102.9% |
| Net Margin | 31.4% | 8.0% | -10.4% | -38.8% | -146.1% | -112.1% |
| EBITDA Margin | 24.5% | 15.8% | -3.2% | -31.0% | -127.2% | -90.3% |
| Liquidity | ||||||
| Current Ratio | 7.14x | 8.30x | 9.30x | 10.66x | 5.11x | 12.36x |
| Quick Ratio | 6.59x | 7.52x | 8.49x | 9.79x | 4.47x | 11.35x |
| Leverage | ||||||
| Debt/Equity | 0.99x | 2.27x | 3.76x | 0.36x | 0.65x | 0.33x |
YoY = year-over-year change. Source: FMP..